Dilip Shanghvi, the founder and managing director (MD) Sun Pharmaceuticals, took a 99 per cent cut in his remuneration in 2018-19, even when the company’s earnings grew by 27 per cent. He is also one of the lowest paying CEOs in the Indian pharma sector.